Clinical Trial Update: A Phase 2a Study of LAM-001 for the Treatment of Pulmonary Hypertension [Phase 2]

View source ↗

Summary

Phase 2a trial of LAM-001 for pulmonary hypertension is currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pulmonary Hypertension

Drugs mentioned

• LAM-001

Snippet

Sponsor: OrphAI Therapeutics | Conditions: Pulmonary Hypertension | Phase 2 | Status: ACTIVE_NOT_RECRUITING